DOC - Educational Analysis * US Equities
Educational Analysis * US Equities

DOC

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerDOC
CategoryEducational primer
Last reviewedNovember 16, 2026
You're viewing an older edition of this page.Read the latest edition →

Business profile & competitive position

Healthpeak Properties, Inc. (DOC) is a Real Estate company classified in the REIT—Healthcare Facilities industry. It is an S&P 500, self-administered UPREIT that owns, operates, and develops U.S. healthcare real estate through its operating subsidiary, Healthpeak OP. As of December 31, 2025, it held interests in 689 properties across outpatient medical buildings and hospitals, lab/life science buildings, and senior housing, with smaller non-reportable investments in loans receivable, preferred equity, and three other properties.

The portfolio-level economics suggest a steady, relationship-driven model rather than a high-leverage, high-growth one. The outpatient medical segment produced $795.8 million in 2025 Adjusted NOI, lab produced $567.4 million, and senior housing produced $176.7 million. Outpatient buildings were roughly 79% on or adjacent to hospital campuses and about 96% affiliated with hospital systems; roughly 72% of that segment was triple-net leased by leased square feet. Lab properties were about 89% triple-net leased and heavily concentrated in San Francisco (59%), Boston (22%), and San Diego (17%) by square feet. The triple-net structure tilts cash-flow visibility toward Healthpeak, but it also means much of property-level cost volatility sits with tenants rather than with the REIT itself.

Financially, a trailing P/E of 36.7, net margin of 12.7%, and ROE of 5.0% point to an asset-heavy, income-oriented business with modest equity returns relative to the broader equity market. Taken together, the numbers are consistent with a healthcare real estate landlord competing on tenant credit quality, location, and balance-sheet capacity rather than on outsized organic growth margins.

Financial posture

Healthpeak currently trades at $19.84 with a market capitalization of about $13.7 billion and a trailing P/E of 36.7. Net margin is 12.7%, ROE is 5.0%, and beta is 0.99, meaning the stock has moved roughly in line with the broader market on a risk-adjusted basis. With a 50-day EMA of $19.83 and an RSI near neutral at 51.9, the price is essentially hugging its medium-term moving average—useful context for a stock that derives much of its investor pitch from dividend yield and balance-sheet stability rather than momentum-driven valuation expansion.

A P/E in the mid-30s alongside 12.7% net margins and 5.0% ROE is not unusual for a healthcare REIT, but it does emphasize that current valuation relies on expectations for stable cash flows and capital appreciation rather than on rapid earnings growth. The company’s self-described priority of maintaining an investment-grade balance sheet with primarily long-term fixed-rate debt and staggered maturities directly affects that valuation case: lower refinancing risk and predictable interest expense support the dividend-growth narrative that income investors typically demand from this sector.

Strategic priorities & outlook

According to its most recent 10-K, Healthpeak’s operational priorities center on owning, operating, and developing high-quality outpatient medical, lab, and senior housing real estate while managing the portfolio for long-term risk-adjusted returns and dividend growth. A core goal is preserving a strong investment-grade balance sheet with ample liquidity and mostly long-term fixed-rate debt, which management sees as a buffer against interest-rate and refinancing risk.

Internal growth is expected to come from tenant renewals, expansions, and relocations, plus lease extensions or modifications before expiration. The company also intends to complete the proposed Janus Living IPO in the first half of 2026, contributing its 34-community senior housing portfolio and retaining a substantial majority ownership interest while serving as external manager. In January 2026, Healthpeak acquired the remaining 46.5% interest in its SWF SH JV, bringing its ownership of those 19 senior housing properties to 100%. That suggests senior housing is becoming a more directly controlled piece of the portfolio, even as the company tries to crystallize value through the public listing.

Macro & geopolitical exposure

As a healthcare REIT, Healthpeak is exposed to a mix of real estate and healthcare-specific macro forces. Interest-rate levels directly affect both cost of debt and the relative attractiveness of REIT dividend yields, while a flattening or inverted yield curve historically complicates refinancing even for well-capitalized landlords. The company’s emphasis on long-term fixed-rate debt with staggered maturities is therefore a direct response to this macro variable.

Regulatory and reimbursement risk is inherent because tenant demand—particularly outpatient clinics, hospitals, and senior housing operators—is tied to Medicare, Medicaid, and broader U.S. healthcare policy. Any changes in reimbursement rates, skilled-nursing regulation, or hospital-affiliation economics flow through to lease renewal probabilities and rent growth. Geographically, lab concentrations in San Francisco, Boston, and San Diego create exposure to local life-science funding, biotech employment, and cost-of-living trends, while outpatient assets’ hospital-campus adjacencies tie performance to regional hospital balance sheets and capital spending. Trade policy is less central here than in manufacturing, but construction costs, labor availability, and building-material inflation can influence development yields. Currency effects are generally limited because the portfolio is U.S.-focused.

Recent developments

Recent headlines place Healthpeak in the broader conversation about healthcare REIT income strategies. On November 12, 2026, Seeking Alpha published “Healthpeak Properties' Scavenger Mentality.” On November 9, 2026, 247wallst.com ran “Doctors' Offices, Labs and Nursing Homes Pay Rent to These 3 REITs, and $150,000 Yields $8,510 a Year.” On November 6, 2026, Seeking Alpha featured “November Buy: 6 IDEAL S&P 500 'Safer' Dividend Dogs.” And on November 5, 2026, defenseworld.net compared “American Healthcare REIT (NYSE:AHR) versus Healthpeak Properties (NYSE:DOC) Head to Head.”

These stories cluster around the same theme: income-oriented investors are reassessing healthcare real estate as a yield anchor, with Healthpeak frequently appearing alongside peers in “safer dividend” lists and head-to-head REIT comparisons. None of the headlines suggests a company-specific event; rather, they reflect the stock’s positioning within a defensive-yield narrative as broader markets weigh interest-rate direction and healthcare policy uncertainty.

Earnings behavior & post-earnings drift

Healthpeak’s earnings track record over the last eight quarters is mixed. It has beaten the official estimate in 3 of the past 8 quarters, or 38% of the time, with an average earnings surprise of just 1.1%. The average 5-day price move in the trading days after earnings was +5.01%, classified as an “up” drift, but that headline figure masks important variation.

The most recent quarter, reported November 2, 2026, is a perfect example of the disconnect: actual EPS of $0.02 missed the $0.06355 estimate by 68.5%, yet the stock rose 0.41% the next day and 5.85% over the following five sessions. By contrast, the August 4, 2026 quarter was a dramatic beat—actual EPS of $0.08 versus an estimate of $0.02815, a 184.2% surprise—but the stock moved only 0.79% the next day and then fell 5.13% over the next five days. The May 5, 2026 quarter was the exception that matched the headline narrative: a $0.28 actual versus $0.05276 estimate (430.7% beat) produced an 18.11% next-day move and a 19.81% five-day drift. The February 2, 2026 quarter saw a miss of 64.4% ($0.16 actual versus $0.45 estimate) with a -2.78% next-day drop and a -0.47% five-day drift.

This pattern is worth internalizing for anyone studying DOC around earnings: beats have not reliably driven continued upside, and misses have not always produced sustained selling. The market appears to react to quarter-to-quarter FFO or EPS prints in a broader context—likely interest-rate expectations, portfolio transactions such as the Janus Living IPO, and rental growth commentary—rather than treating the headline beat or miss as the entire story. The next scheduled report is February 1, 2027, after the close, with the consensus EPS estimate at $0.03522.

For a deeper picture of where the Street stands on Healthpeak right now—covering buy/hold/sell breakdowns, model revisions, and forward estimates—readers should review the full institutional verdict rather than relying on the print alone.

Frequently Asked Questions

What does Healthpeak Properties actually own?

As of December 31, 2025, Healthpeak owned interests in 689 properties focused on outpatient medical buildings and hospitals, lab/life science buildings, and senior housing. The 2025 reportable segment Adjusted NOI was $795.8 million from outpatient medical, $567.4 million from lab, and $176.7 million from senior housing.

How has DOC performed around earnings?

Over the last eight reported quarters, DOC beat estimates 3 times (38%) with an average surprise of 1.1%. While the average 5-day post-earnings drift was +5.01%, the reaction has been inconsistent: for example, the August 2026 beat produced a 0.79% next-day gain but a -5.13% five-day drift, while the November 2026 miss was followed by a +5.85% five-day move.

What are Healthpeak's stated priorities?

Healthpeak's 10-K emphasizes owning and developing outpatient medical, lab, and senior housing real estate, managing for risk-adjusted returns and dividend growth, maintaining an investment-grade balance sheet, and completing the proposed Janus Living IPO of its senior housing portfolio in the first half of 2026.

Real Data - Gamma QC Earnings IntelligenceAs of Nov 16, 2026
Healthpeak Properties, Inc. · Real Estate / REIT - Healthcare Facilities
$13.7BMarket cap
36.7P/E
12.7%Net margin
5.0%ROE
38%Beat rate, last 8Q
1.1%Avg EPS surprise
5.01%Avg 5-day move after earnings
2027-02-01Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-11-02$0.02$0.06355-68.5%+0.41%+5.85%
2026-08-04$0.08$0.02815+184.2%+0.79%-5.13%
2026-05-05$0.28$0.05276+430.7%+18.11%+19.81%
2026-02-02$0.16$0.45-64.4%-2.78%-0.47%
2025-10-23$-0.17$0.06-383.3%--
2025-07-24$0.05$0.06399-21.9%--

Previous DOC editions

Beyond the primer

Get the institutional verdict on DOC

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the DOC verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.